West Lafayette-based Bioanalytical Systems Inc. (Nasdaq: BASI) has selected Beth Taylor as chief financial officer. Taylor most recently served as vice president of finance and chief accounting officer at Endocyte Inc., also based in the Tippecanoe County city, which was acquired in late 2018.
Taylor succeeds Jill Blumhoff, who had served in the role since May 2016. The pharmaceutical development company, which does business as Inotiv, cited Taylor’s expertise in business planning, technical accounting, compliance and investor relations in its decision to hire her for the position.
“I am pleased to welcome Beth to our team and look forward to her contributions in driving our shared vision for growth and success,” said Robert Leasure Jr, chief executive officer of BASi, said in a news release. “Beth has the experience and business acumen necessary to lead the Company’s financial and accounting team with the goal of continuing to increase confidence and shareholder value for our evolving Company. I would also like to thank Jill Blumhoff for her hard work and dedication to the Company and wish her well in her future endeavors.”
In addition to her work at Endocyte, Taylor also previously held financial leadership positions at several companies, including Republic Airways Holdings and Rolls-Royce Corp.